Cartesian Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $-759 | $387 | $33,445 | $5,840 |
Gross Profit | -759 | 387 | 33,249 | 5,657 |
EBITDA | -9,480 | -23,897 | 14,032 | -56,641 |
EBIT | -9,966 | -24,183 | 13,836 | -56,824 |
Net Income | -10,253 | -24,183 | 13,836 | -56,824 |
Net Change In Cash | -759 | 387 | 33,445 | 5,840 |
Free Cash Flow | -7,707 | 7,492 | -16,033 | -16,519 |
Cash | 212,610 | 219,198 | 87,227 | 103,418 |
Basic Shares | 155,109 | 143,142 | 142,329 | 135,350 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $38,913 | $26,004 | $110,777 | $85,077 |
Gross Profit | 38,913 | 24,451 | 108,740 | 85,077 |
EBITDA | -75,986 | -235,064 | 39,838 | -5,158 |
EBIT | -77,137 | -235,907 | 37,801 | -6,877 |
Net Income | -77,424 | -219,710 | 35,379 | -25,687 |
Net Change In Cash | 38,913 | 26,004 | 110,777 | 85,077 |
Cost of Revenue | -7,418 | -24,628 | ||
Free Cash Flow | -32,767 | -51,367 | -32,832 | -61,467 |
Cash | 212,610 | 76,911 | 106,438 | 114,057 |
Basic Shares | 155,109 | 129,257 | 121,562 | 95,273 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.59 |
2024-09-30 | -$1.13 |
2024-06-30 | $0.54 |
2024-03-31 | -$10.50 |
